207 related articles for article (PubMed ID: 28002762)
1. Long-circulating polyhydroxybutyrate-co-hydroxyvalerate nanoparticles for tumor targeted docetaxel delivery: Formulation, optimization and in vitro characterization.
Vardhan H; Mittal P; Adena SK; Mishra B
Eur J Pharm Sci; 2017 Mar; 99():85-94. PubMed ID: 28002762
[TBL] [Abstract][Full Text] [Related]
2. Development of long-circulating docetaxel loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles: Optimization, pharmacokinetic, cytotoxicity and in vivo assessments.
Vardhan H; Mittal P; Adena SKR; Upadhyay M; Mishra B
Int J Biol Macromol; 2017 Oct; 103():791-801. PubMed ID: 28536023
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of long-acting insulin formulation based on poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) nanoparticles: preparation, optimization, characterization, and in vitro evaluation.
Bayrami S; Esmaili Z; SeyedAlinaghi S; Jamali Moghadam SR; Bayrami S; Akbari Javar H; Rafiee Tehrani M; Dorkoosh FA
Pharm Dev Technol; 2019 Feb; 24(2):176-188. PubMed ID: 29557733
[TBL] [Abstract][Full Text] [Related]
4. Process optimization and in vivo performance of docetaxel loaded PHBV-TPGS therapeutic vesicles: A synergistic approach.
Vardhan H; Mittal P; Adena SKR; Upadhyay M; Yadav SK; Mishra B
Int J Biol Macromol; 2018 Mar; 108():729-743. PubMed ID: 29111267
[TBL] [Abstract][Full Text] [Related]
5. Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.
Adena SKR; Upadhyay M; Vardhan H; Mishra B
Drug Dev Ind Pharm; 2018 Mar; 44(3):493-501. PubMed ID: 29161920
[TBL] [Abstract][Full Text] [Related]
6. Multivariate Optimization of Rizatriptan Benzoate-Loaded Solid Lipid Nanoparticles for Brain Targeting and Migraine Management.
Girotra P; Singh SK
AAPS PharmSciTech; 2017 Feb; 18(2):517-528. PubMed ID: 27126007
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of carboplatin-loaded PCL nanoparticles for intranasal delivery.
Alex AT; Joseph A; Shavi G; Rao JV; Udupa N
Drug Deliv; 2016 Sep; 23(7):2144-2153. PubMed ID: 25544603
[TBL] [Abstract][Full Text] [Related]
8. Prolonged injectable formulation of Nafarelin using in situ gel combination delivery system.
Alizadeh B; Bahari Javan N; Akbari Javar H; Khoshayand MR; Dorkoosh F
Pharm Dev Technol; 2018 Feb; 23(2):132-144. PubMed ID: 28430010
[TBL] [Abstract][Full Text] [Related]
9. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the Box-Behnken experimental design.
Gajra B; Patel RR; Dalwadi C
Drug Dev Ind Pharm; 2016; 42(5):747-57. PubMed ID: 26559522
[TBL] [Abstract][Full Text] [Related]
10. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
11. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
[TBL] [Abstract][Full Text] [Related]
12. Implementation of two different experimental designs for screening and optimization of process parameters for metformin-loaded carboxymethyl chitosan formulation.
De A; Kuppuswamy G; Jaiswal A
Drug Dev Ind Pharm; 2019 Nov; 45(11):1821-1834. PubMed ID: 31486683
[TBL] [Abstract][Full Text] [Related]
13. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer.
Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA
Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589
[TBL] [Abstract][Full Text] [Related]
14. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization, and optimization of altretamine-loaded solid lipid nanoparticles using Box-Behnken design and response surface methodology.
Gidwani B; Vyas A
Artif Cells Nanomed Biotechnol; 2016; 44(2):571-80. PubMed ID: 25363752
[TBL] [Abstract][Full Text] [Related]
16. Preparation, Optimization and Physicochemical Characterization of Aripiprazole Loaded Nano-porous in situ Forming Implant.
Hedayati A; Yazdi SG; Dehghankelishadi P; Javan NB; Akbari H; Dorkoosh FA
Pharm Nanotechnol; 2017; 5(2):138-147. PubMed ID: 28530539
[TBL] [Abstract][Full Text] [Related]
17. Effects of Formulation Variables on the Particle Size and Drug Encapsulation of Imatinib-Loaded Solid Lipid Nanoparticles.
Gupta B; Poudel BK; Pathak S; Tak JW; Lee HH; Jeong JH; Choi HG; Yong CS; Kim JO
AAPS PharmSciTech; 2016 Jun; 17(3):652-62. PubMed ID: 26304931
[TBL] [Abstract][Full Text] [Related]
18. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease.
Sinhmar GK; Shah NN; Chokshi NV; Khatri HN; Patel MM
Drug Dev Ind Pharm; 2018 Jul; 44(7):1078-1089. PubMed ID: 29376433
[TBL] [Abstract][Full Text] [Related]
19. Encapsulation of Ellipticine in poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) based nanoparticles and its in vitro application.
Masood F; Chen P; Yasin T; Fatima N; Hasan F; Hameed A
Mater Sci Eng C Mater Biol Appl; 2013 Apr; 33(3):1054-60. PubMed ID: 23827542
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach.
Yerlikaya F; Ozgen A; Vural I; Guven O; Karaagaoglu E; Khan MA; Capan Y
J Pharm Sci; 2013 Oct; 102(10):3748-61. PubMed ID: 23918313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]